Vertex Pharmaceuticals Inc. late Wednesday expanded its public stock offering to 11.5 million shares from 10 million, priced at $38.50 each for gross proceeds of $442.8 million. The underwriters will have an option to buy another 1.5 million shares, Vertex…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




Stock – Vertex Pharmaceutical – Goldman Sachs – Underwriting – Business

Read the original post:
Vertex Pharma plans to sell 11.5M shares